Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danbury Proton is a Connecticut-based healthcare company developing a proton therapy cancer treatment center in Danbury. The company is focused on delivering outpatient proton beam radiation therapy for patients with cancer, using a Mevion S250i system with Hyperscan and Adaptive Aperture for pencil beam scanning and intensity modulated proton therapy. Danbury Proton received Connecticut Certificate of Need approval via settlement with the Office of Health Strategy in January 2025 to establish a single-room proton therapy center, with design capacity for a second room in the future. The planned facility is positioned as one of the first proton therapy offerings in Connecticut and is intended to improve regional access to advanced radiation oncology care. The business appears to be a project-stage treatment provider rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danbury Proton.